BioSpace News Archive

GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that it will host a conference call and webcast to report first quarter financial results on Monday, May 3, 2021, at 8:30 a.m. ET.

Urges Stockholders to Vote on the GREEN Proxy Card Today to Elect Sonic’s Three Independent Director Nominees to Drastically Improve Board

This natural biological approach to crop protection underscores the “E” in ESG - Environmental, Social, and Governance.

The Financing is anticipated to close on or about April 27, 2021, subject to approval by the TSX Venture Exchange (the “Exchange”).

To Date, 22nd Century Has Provided More Than 31 Million Variable Nicotine Content Research Cigarettes for Numerous Independent Scientific Studies

The American College of Radiology® (ACR®) Data Science Institute® (DSI) and the Cancer Imaging Archive (TCIA), funded by the National Cancer Institute (NCI), have teamed up to connect use cases and datasets to speed medical imaging artificial intelligence (AI) development.

In addition, 175,000 incentive stock options were granted to consultants exercisable at a price of $1.65 per share for a period of three to five years and that vest equally either every three months over a one-year period or each month over a one-year period.

OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) and Veloxis Pharmaceuticals Inc., a subsidiary of Asahi Kasei, today announced a global license agreement granting Veloxis Pharmaceuticals worldwide rights to develop, manufacture and commercialize FR104, a CD28 antagonist monoclonal antibody fragment, for all transplant indications

New partnerships, collaborations and services across Canada are continuing the drive to unite the country’s fragmented agriculture and agri-food innovation system.

BENEV Company Inc., an FDA registered manufacturer with global presence, is proud to announce the launching of a novel RF micro-needling device, Sylfirm X, in the U.S. as the exclusive distributor.